These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Plasma homocysteine, folate, and vitamin B 12 and the risk of hip fracture: the hordaland homocysteine study. Gjesdal CG, Vollset SE, Ueland PM, Refsum H, Meyer HE, Tell GS. J Bone Miner Res; 2007 May; 22(5):747-56. PubMed ID: 17295607 [Abstract] [Full Text] [Related]
9. Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial. Bauer DC, Black DM, Garnero P, Hochberg M, Ott S, Orloff J, Thompson DE, Ewing SK, Delmas PD, Fracture Intervention Trial Study Group. J Bone Miner Res; 2004 Aug; 19(8):1250-8. PubMed ID: 15231011 [Abstract] [Full Text] [Related]
16. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. Dhonukshe-Rutten RA, Pluijm SM, de Groot LC, Lips P, Smit JH, van Staveren WA. J Bone Miner Res; 2005 Jun; 20(6):921-9. PubMed ID: 15883631 [Abstract] [Full Text] [Related]
19. Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson's disease. Lee SH, Kim MJ, Kim BJ, Kim SR, Chun S, Kim HK, Ryu JS, Kim GS, Lee MC, Chung SJ, Koh JM. Calcif Tissue Int; 2010 Feb; 86(2):132-41. PubMed ID: 20049422 [Abstract] [Full Text] [Related]
20. Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study. Garnero P, Mulleman D, Munoz F, Sornay-Rendu E, Delmas PD. J Bone Miner Res; 2003 Oct; 18(10):1789-94. PubMed ID: 14584889 [Abstract] [Full Text] [Related] Page: [Next] [New Search]